key: cord-0279973-pzfop9ai
authors: Jeong, Y. D.; Ejima, K.; Kim, K. S.; Iwanami, S.; Iwami, S.; Aihara, K.
title: Safely return to schools and offices: early and frequent screening with high sensitivity antigen tests effectively identifies COVID-19 patients
date: 2021-10-11
journal: nan
DOI: 10.1101/2021.10.08.21264782
sha: 890d7c3d67f39f40bc3281453fb7722bb9aa6c30
doc_id: 279973
cord_uid: pzfop9ai

Background: In-person interaction at school and offices offers invaluable experience to students and benefits to companies. In the midst of the pandemic, ways to safely go back to schools and offices have been argued. Centers for Disease Control and Prevention (CDC) recommends taking all precautions such as vaccination and universal indoor masking. However, even if all the precautions are implemented and transmission is perfectly prevented in the facilities, they may be infected outside of the facilities, which would be a source of transmission in the facilities. Therefore, identifying those infected outside of the facility through screening is essential to safely go back to schools or offices. However, studies investigating the effectiveness of screening are limited. Further, it is not well clarified now which screening strategy (e.g., low or high sensitivity antigen tests, intervals and the number of tests) effectively identify infected and infectious individuals to avoid transmission in facilities Methods: We assessed the effectiveness of various screening strategies in schools and offices through quantitative simulation. The effectiveness was assessed by the proportion of identified infected and infectious participants. Infection dynamics in the facility is governed by transmission dynamics of the population they belong to, and the screening is initiated at different epidemic phases: growth, peak, and declining phases. The viral load trajectory over time for each infected individual was modelled by the viral dynamics model, and the transmission process at the population level was modelled by a deterministic compartment model. The model parameters were estimated from clinical and epidemiological data. Screening strategies were varied by antigen tests with different sensitivity and schedules of screening over 10 days. Results: Under the daily screening, we found high sensitivity antigen tests (the detection limit: 63000 copies/mL) yielded 88% (95%CI 86-89) of effectiveness by the end of 10 days screening period, which is about 20% higher than that with low sensitivity antigen tests (2000000 copies/mL). Comparing screening scenarios with different schedules, we found early and frequent screening is the key to maximize the effectiveness. Sensitivity analysis revealed that less frequent tests might be an option when the number of antigen tests is limited especially when the screening is performed at the growth phase. Discussion: High sensitivity antigen tests, high frequency screening, and immediate initiation of screening are the key to safely restart educational and economic activities allowing in-person interactions. Our computational framework is useful in assessment of screening strategies by incorporating additional factors for specific situations.

In-person interaction at school and offices offers invaluable experience to students and benefits to 25 companies. In the midst of the pandemic, ways to safely go back to schools and offices have been argued. 26

Centers for Disease Control and Prevention (CDC) recommends taking all precautions such as vaccination 27 and universal indoor masking. However, even if all the precautions are implemented and transmission is 28 perfectly prevented in the facilities, they may be infected outside of the facilities, which would be a source 29 of transmission in the facilities. Therefore, identifying those infected outside of the facility through 30 screening is essential to safely go back to schools or offices. However, studies investigating the 31 effectiveness of screening are limited. Further, it is not well clarified now which screening strategy (e.g., 32 low or high sensitivity antigen tests, intervals and the number of tests) effectively identify infected and 33 infectious individuals to avoid transmission in facilities 34 35

We assessed the effectiveness of various screening strategies in schools and offices through quantitative 37 simulation. The effectiveness was assessed by the proportion of identified infected and infectious 38 participants. Infection dynamics in the facility is governed by transmission dynamics of the population they 39 belong to, and the screening is initiated at different epidemic phases: growth, peak, and declining phases. 40

The viral load trajectory over time for each infected individual was modelled by the viral dynamics model, 41 and the transmission process at the population level was modelled by a deterministic compartment model. 42

The model parameters were estimated from clinical and epidemiological data. Screening strategies were 43 varied by antigen tests with different sensitivity and schedules of screening over 10 days. 44 45

Under the daily screening, we found high sensitivity antigen tests (the detection limit:

. 3 ൈ 1 0 ସ copies/mL) 47 yielded 88% (95%CI 86-89) of effectiveness by the end of 10 days screening period, which is about 20% 48 higher than that with low sensitivity antigen tests (2.0 with different schedules, we found early and frequent screening is the key to maximize the effectiveness. 50 Sensitivity analysis revealed that less frequent tests might be an option when the number of antigen tests is 51 limited especially when the screening is performed at the growth phase. 52 53 Discussion: 54

High sensitivity antigen tests, high frequency screening, and immediate initiation of screening are the key to 55 safely restart educational and economic activities allowing in-person interactions. Our computational 56 framework is useful in assessment of screening strategies by incorporating additional factors for specific 57 situations. 58 59 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

Multiple screening strategies were considered. The screening strategies are composed of multiple 113 factors: 1. sensitivity of antigen tests, 2. a screening schedule over the screening period (10 days). For the 114 assessment of effectiveness of screening, we use the proportions of infected cases identified through the 115 screening strategy among all infected cases. Screening simulation was performed 30 times for each setting. 116

Below we describe the detail of the data, the models, and the simulation. 117 118 Viral load data 119

Longitudinal viral load data of symptomatic and asymptomatic COVID-19 patients were searched 120 through PubMed and Google scholar. The data that meet following criteria are used to estimate parameters 121 of the viral dynamics model: 1) viral loads were measured and reported at least at two time points; 2) 122 samples were collected from upper respiratory specimens, such as nose and pharynx; 3) patients who did not 123 receive antiviral therapy were included. As all the data were extracted from published papers, ethics 124 approval was not required in this study. 125

To describe the temporal change in viral load of each infected individual in the school or the office, a 128 mathematical model describing the viral dynamics of SARS-CoV-2 was employed as in our previous studies 129 (Ejima, Kim, Iwanami, et . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint observed for patients, we estimated the timing of infection as well 140 Ejima, Kim, Ludema, et al., 2021) . Note that the model parameters were estimated for symptomatic and 141 asymptomatic patients (Fig. 1C) . 142

The estimated parameters are used for simulating viral load trajectories of those infected cases in the 143 school or office. To account for the measurement error, we also computed "measured" viral load, , is generated by running the viral dynamics model with a parameter set, which is resampled from 146 the estimated distributions. The measured viral load for the patient ݇ is computed by adding an error term: 147

. The variance of the error term, The parameters related to the disease progression are informed from the viral dynamics model (Fig.  159   1B) . Specifically, the pre-infectious period, . Note that 165 this process is performed for symptomatic cases and asymptomatic cases independently. 166 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint

The proportion of asymptomatic cases, ‫‬ , is set as 0.17 (Byambasuren et al., 2020 (Burki, 2021) . All estimated and 171 assumed model parameters are summarized in Table S3 . 172 173 Simulation of screening COVID-19 patients 174

Using the above two models (i.e., the viral dynamics model and the transmission model), we assess 175 the effectiveness of various screening strategies. The effectiveness is assessed by three metrics counting 176 infected cases: the proportions of infected cases (pre-infectious, infectious, and non-infectious) identified 177 through the screening strategy among all infected cases. We further computed the breakdown as we believe 178 that identifying pre-infectious and infectious patients and identifying non-infectious patients have different 179 implications from public health perspectives. We computed these metrics for those infected (a) at the start of 180 screening and (b) at the start of screening and during the screening period (10 days). In other words, the 181 latter includes those infected during the screening period (thus in addition to the numerator [identified cases], 182 the denominator [all infected cases] increases during the screening period). 183

The size of the school or the office is assumed to be 1000. Their risk of infection is determined by 184 the risk of community, thus if the total attack rate in the community by the end of the epidemic is ‫ܣ‬ ܴ , then 185 final size of the school or the office is . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint Screening with antigen tests is performed four times with different schedules over the screening 193 period (10 days): (1) everyday (Day 0, 1, 2, 3), (2) two days interval (Day 0, 2, 4, 6), (3) three days interval 194 (Day 0, 3, 6, 9), (4) late screening (Day 0, 8, 9, 10), and (5) random screening (the timing of test is 195 determined randomly over the 10 days) ( Fig. 2A) . We also performed the simulation with daily screening to 196 explore key parameters associated with high effectiveness of the screening. Beside the screening tests, 197 patents are further identified through symptom presence. Thus symptomatic cases could be identified either 198 symptom onset (an incubation period of each case is randomly determined from the distribution previously 199 estimated: Screening is initiated at different epidemic phases: growth, peak, and declining phases. Note that the 202 epidemiological dynamics would not be influenced by screening tests, because we assume a community of 203 large population and a school or an office of considerably small population. Further, we assume that no 204 transmission occurs in the school or the office, which is a reasonable assumption given the observation that 205 the transmission risk is limited at schools and offices where precautions are implemented (Lessler et al., 206 2021 ). Therefore, we assumed identified cases at the school or office are infected in the community, but 207 outside of the facility. In other words, the risk of infection for those in the school or the office is the same as 208 the risk in the community. As sensitivity analyses, the simulation was performed varying the number of 209 antigen tests (2 to 5) and the length of the screening period (10 to 30 days). 210

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint

10 papers were identified which met all the inclusion criteria. In total, the viral load data of 109 213 symptomatic patients and 101 asymptomatic patients were used for parameter estimation of the viral 214 dynamics model. Seven studies were from Asia and two were from USA. The other was from Europe 215 (Table S1) . 216

The viral dynamics model was fitted to the longitudinal viral load data from the symptomatic and 217 asymptomatic patients (Fig. S1, S2 and Table S2 ). We observed difference on the peak viral load and the 218 duration of viral shedding between groups, but not on the time of the peak viral load (Fig. 1C) . Considering 219 viral load dynamics observed here, we evaluated effectiveness of screening strategies as below. 220 221

The daily incidence at the community peaks at the epidemic day 22 and the epidemic disappears in 223 40 days because of the high transmission potential of the delta variant (ܴ ൌ 7 . 0 ) (Fig. 1D) , thus

For the screening simulation, the screening starts at epidemic day 12, 22, and 32, each of which corresponds 225 to growth, peak, and decline phases of the epidemic. Because the infection risk for those at the school and 226 the office is dependent on that of the community, the epidemic curve at the facility is proportional to that of 227 the community (Fig. 1E) . At the growth phase, more cases at the first screening are pre-infectious and with 228 low viral load (24%) because time does not pass much since infection by the time, whereas more cases are 229 already infectious and with high viral load at the decline phase (42%) (Fig. S3) . 230

The effectiveness of different screening strategies was assessed based on the proportion of identified 231 cases through the screening. To identify key parameters associated with high effectiveness of screening, we 232 first performed simulation with daily screening. When those who infected during the screening period were 233 not included in the effectiveness assessment, the proportion of identified cases monotonically increases 234 during the screening period, as they are identified by multiple testing or symptom presence ( Fig. 2B and Fig.  235   S4A) . The proportion saturates around Day 5 because the viral load drops below the detection limit of the 236 tests for most cases who infected before the initiation of screening by this time. Screening using high 237 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint sensitivity antigen tests could identify twice as many as patients compared with that using low sensitivity 238 antigen tests on Day 0, and the effectiveness remains higher over the screening period. 239

The temporal behavior of the proportion of identified cases is different depending on the epidemic 240 phase when the screening is performed. At the growth phase, the first screening test cannot capture the cases 241 who have not presented symptoms (but will present symptoms later) and those with low viral load below the 242 detection limit because more cases are recently infected (Fig. S3) , thus the proportion is lower than that for 243 the decline phase: 8% (95%CI: 6-10) and 17% (95%CI: 15-19) for low and high sensitivity antigen tests, 244 respectively (Fig. 2B top) . The proportion reaches 69% (95%CI: 66-71) and 88% (95%CI: 86-89) by the 245 end of screening (Fig. 2B top) . When the screening starts at the decline phase, more patents could be 246 identified by the first day because of symptom presence and high viral load (Fig. 2B bottom) ; however, the 247 proportion reaches 46% (95%CI: 40-50) and 73% (95%CI: 69-77) by the end of screening with low and 248 high sensitivity antigen tests, respectively (Fig. 2B bottom) . The proportions with the screening at the 249 decline phase cannot reach those with the screening at the growth phase, because more patients are already 250 non-infectious and the viral load drops below the detection limits (Fig. S3) . Note that symptomatic patients 251 were detected by either screening tests or symptom presence (Fig. S4A) . Overall, high sensitivity antigen 252 tests can identify about 20% more cases under everyday screening regardless of the timing of screening 253 initiation. 254

The simulation is performed for different scenarios with high sensitivity antigen tests due to its high 255 effectiveness ( Fig. 2A) . We primarily focus on the proportion of cases identified through simulation, and 256 further computed the breakdown (i.e., pre-infectious, infectious, and non-infectious cases). Regardless of the 257 epidemic phase, early and frequent screening (such as Scenarios 1 and 2, which perform test every day or 258 with two days interval) can identify more cases because cases are identified when their viral load is still high 259 (Fig. 2C) . Indeed, when the screening is started at the growth phase, Scenario 1 (everyday screening) 260 yielded to 77% (95% CI: 75-79) of total cases identified, whereas it was 33% (95% CI: 31-35) for Scenario 261 4 (late screening). The difference between scenarios shrinks when the screening is performed at the decline 262 phase due to limited new infections. Such difference becomes clear when we focus on the proportion of 263 identified pre-infectious cases. The contribution of pre-infectious to the proportion of total cases is 264 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint substantial when the screening is performed at the growth phase (20% under Scenario 1), whereas more 265 cases are identified at non-infectious phase when the screening is performed at the decline phase (18% under 266 Scenario 1). We also found that the proportion of identified asymptomatic cases are influenced by scenarios 267 and epidemic phases (see Fig. S4B ). Over 90% of asymptomatic patients are identified by early and frequent 268 screening (Scenario 2) in the growth phase, but the proportion drops to around 60% even under the best 269 scenario (i.e., Scenario 1) in the decline phase because many of asymptomatic patients are infected long 270 before the screening and their viral load is below the detection limit at the timing of screening. 271 Sensitivity analyses were performed by varying the number of high sensitivity antigen tests and the 272 length of screening period to see if the best scenario (with the highest proportion of identified cases) could 273 be influenced by those parameters (Fig. S4C) . The length of the screening period did not impact on the best 274 scenario; however, the best scenario shift towards less frequent testswhen the number of antigen tests is 275 limited especially when the screening is performed at the growth phase. This is because some of pre-276 infectious cases under detection limit cannot be identified at the first few days; in other words, the best 277 scenario was robust when the screening is performed at the decline phase due to the limited number of new 278 infection (thus pre-infectious cases). 279

We further performed the analyses including those infected during the screening period (Fig. 2DE  280 and Fig. S5) . Compared with the analyses excluding those infected during the screening period, as both the 281 numbers of cases (denominator) and identified cases (numerator) increase over time, the proportion of 282 identified cases does not necessarily increase, which is more drastic when the screening is performed when 283 epidemic is still growing (Fig. 2D top) . Under the 5 scenarios for the growth phase, fewer than 4% of total 284 infected individuals are identified (Fig. 2E top) . In the peak phase, about 50% of infected cases are 285 identified by the daily screening (Fig. 2D middle) . This is because both the limited new incidence and viral 286 loads which are high enough to be identified ( Fig. 1E and S3) . Under the 5 scenarios, Scenario 1 and 2 287 identified around 50% of infected cases (Fig. 2E middle) . Among those identified cases by screening at the 288 peak phase, 60% of asymptomatic patients and 40% of pre-symptomatic patients were identified by early 289 and frequent screening (Scenario 1 and 2), respectively (Fig. S5B, middle) . As new cases are limited when 290 the screening is performed at the decline phase, the proportion looks monotonically increasing (Fig. 2D  291 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint bottom). In this phase, the high sensitivity antigen tests identified about 20% of infected cases regardless of 292 the scenarios (Fig. 2E, bottom) . Other results such as the best scenario were consistent with those when 293 only cases infected before the screening initiation were considered (Fig. S5C) . 294 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint

Our society is seeking for approaches to safely restart economic and educational activities involving 296 in-person interactions in midst of the pandemic. Along with precautious measures, screening is considered 297 as a key to mitigate the risk of infection allowing in-person interactions. We assessed the effectiveness of 298 screening strategies using antigen tests through simulation. 299

In the simulation, the transmission model and the viral dynamics model were combined to 300 incorporate both epidemiological dynamics and within-person biological dynamics, because both factors 301 influence the assessment of the effectiveness of screening strategies. To parameterize the model, we used 302 longitudinal viral load data for the viral dynamics model and epidemiological parameters, a part of which 303 were informed from the viral dynamics model, for the transmission model. To identify key parameters for 304 effective strategies, we first performed daily screening initiated at different epidemic phases (early, peak, 305 decline phases). If the screening is performed every day for 10 days, 69 % and 88 % of infected individuals 306 could be identified by screening with low and high sensitivity antigen tests, respectively. The proportion 307 declines to 46 % and 73 % when the screening is initiated at the decline phase of the epidemic; however, this 308 is mainly because of those cases who are already not infectious. Therefore, high sensitivity antigen tests 309 yielded 20% more cases identified through the everyday screening regardless of the timing of screening 310 initiation. 311

Next, we further performed simulation to assess the effectiveness of screening under different 312 schedules, varying four times tests (high sensitivity antigen tests) over 10 days of the screening period. 313

Regardless of the epidemic phase, we found early and frequent screening yielded high effectiveness, because 314 more cases are identified while their viral load is high. Sensitivity analyses revealed that the best effective 315 scenario shifts toward less frequent tests when the number of antigen tests is limited especially when the 316 screening is performed at the growth phase. Overall, our simulation suggested early and frequent screening 317 with high sensitivity antigen tests can identify more cases. 318

This is the first study that assessed the effectiveness of screening strategies with antigen tests in 319 schools or offices. There is a study focusing on entire population, suggesting that frequent screening tests 320 with fast turnaround time is key to mitigate the transmission risk in the population (Larremore et al., 2021) . 321 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint Compared with this study, our study is unique because we focused on a small group (i.e., a school or an 322 office) as the screening target, given that screening in a huge population does not seem realistic. Therefore, 323 the screening does not influence on the epidemiological dynamics in the community, and we could 324 separately argue the transmission in the community and the screening effectiveness in a school or an office. 325

Further we assumed the limited screening period. Although antigen screening is less expensive compared 326 with PCR tests, enforcing all people to get tested over the pandemic period is challenging. 327

In this study, we used antigen tests rather than PCR testing, because using PCR testing for screening 328 purpose is practically challenging given the cost and turnaround time (2 days (Larremore et al., 2021) ). 329

There are multiple antigen tests with varying sensitivity (Yamaoka et al., 2021) . Although our study did not 330 investigate the difference in cost between different antigen tests, we found that high sensitivity antigen tests 331 among all antigen tests available so far yielded 20% more identified cases than low sensitivity antigen tests 332 if the screening is implemented every day over 10 days. 333

We did not directly consider the cost of antigen tests, however, if available antigen tests are limited, 334 early and frequent screening might not be the best strategy. Rather than that, screening with a few days' 335 interval might be an option to wait until those who have just been infected with low viral load will be 336 detected by antigen tests. Under resource limited circumstances, the screening schedule needs to be 337 reconsidered. However, our computational framework is flexible enough to assess the effectiveness of 338 screening strategy accounting for such situation. 339

Regardless of the flexibility of the simulation framework, there are a few limitations which need to 340 be addressed in future studies. First, we did not consider false-positive rate of the antigen tests (specificity of 341 antigen tests for SARS-CoV-2: 99.6% (Dinnes et al., 2021) ). Especially in screening settings under low 342 prevalence, even a small false positive rate would be an issue. For example, if the prevalence is 1% (and the 343 sensitivity is 100%), the screening test with 99% sensitivity will produce almost the same number of false 344 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint that the delta variant presented faster viral replication (B. Li et al., 2021)), our model needs to be updated. 349

However, we anticipate that faster viral replication would not influence our findings because the replication 350 speed is associated with the length that the virus cannot be detected, which is already less than In conclusion, to safely open our economic and educational activities , we recommend that frequent 357 and early screening with high sensitivity antigen tests will substantially mitigate the risk of transmission in a 358 school or an office. We believe that our computational framework would be helpful to assess the 359 effectiveness of various screening strategies under different circumstances including emergence of new 360 variants. 361 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 11, 2021. ; https://doi.org/10.1101/2021.10.08.21264782 doi: medRxiv preprint during screening. Note that in (B)-(E), first, second, and third rows of panels correspond to the results for 551 the screening initiated in the growth, peak, and decline phases of the epidemic, respectively. 552 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Days after infection Viral RNA load (copies/mL) Symptomatic Asymptomatic 10 6.7 copies/mL 10 5.9 copies/mL Peak viral load 20.9 days 24.7 days

Days after the first test 0 1 2 3 4 5 6 7 8 9 10

Days after the first test 0 1 2 3 4 5 6 7 8 9 10

Days after the first test 0 1 2 3 4 5 6 7 8 9 10

Days after the first test 0 1 2 3 4 5 6 7 8 9 10

Days after the first test 0 1 2 3 4 5 6 7 8 9 10

Randomly determined timing of test 

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

What Jobs are Being Done at 394 Home During the Covid-19 Crisis? Evidence from Firm-Level Surveys

A survey of perceptions of remote work and work productivity in the United 397 States during the COVID-19 shutdown

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral 403 strategies. Proceedings of the National Academy of Sciences of the United States of America

Reproductive number of coronavirus: A systematic 406 review and meta-analysis based on global level evidence

Negative Impacts From the Shift to Online Learning 409 During the COVID-19 Crisis: Evidence from a Statewide Community College System

Lifting of COVID-19 restrictions in the UK and the Delta variant

Estimating the 414 extent of asymptomatic COVID-19 and its potential for community transmission: systematic review 415 and meta-analysis

Guidance for COVID-19 Prevention in K-12 Schools

Change in Reported Adherence to 423 Nonpharmaceutical Interventions During the COVID-19 Pandemic

Rapid, point 426 -of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection

Time variation in the 429 probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as 430 estimated from a viral dynamics model

Estimation of 433 the incubation period of COVID-19 using viral load data

Quantifying population contact patterns in the United States 436 during the COVID-19 pandemic

Work From Home During the 439 COVID-19 Outbreak: The Impact on Employees' Remote Work Productivity

Timing of

Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load

Viral load and 446 contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events

Mental Health and Behavior of College Students During the Early Phases of the COVID-19 450 Pandemic: Longitudinal Smartphone and Ecological Momentary Assessment Study

Detection 453 of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized 454 controlled trials: A modeling study

Revisiting 457 the guidelines for ending isolation for COVID-19 patients

Neutralizing antibody levels are highly predictive of immune protection from symptomatic 460 SARS-CoV-2 infection

A quantitative 462 model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides 463 insights into the pathogenesis and treatment of SARS-CoV-2

Infections in Residents of a Long-Term Care 467 Skilled Nursing Facility

Test 470 sensitivity is secondary to frequency and turnaround time for COVID-19 screening

Household COVID-19 risk and in-person schooling

Viral infection and transmission in a 476 large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. medRxiv

The Psychological Impacts of a COVID-19 479 Outbreak on College Students in China: A Longitudinal Study

Determinants of COVID-19 vaccine 482 acceptance in the US

Quantifying the relationship between SARS-CoV-2 viral load and infectiousness. medRxiv

Dynamics 486 of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. The 487 Lancet Regional Health -Europe

Closure of Universities Due to Coronavirus Disease 2019 (COVID-19): Impact on 489 Education and Mental Health of Students and Academic Staff

COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

Social Isolation and Stress as Predictors of Productivity Perception and 498

Remote Work Satisfaction during the COVID-19 Pandemic: The Role of Concern about the Virus in 499 a Moderated Double Mediation

Duration and key determinants of infectious virus shedding in hospitalized 502 patients with coronavirus disease-2019 (COVID-19)

Immediate Psychological 504 Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease 505 (COVID-19) Epidemic among the General Population in China

Virological assessment of hospitalized patients with COVID-2019

Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid 511 protein for antigen detection tests

The effects of remote 513 work on collaboration among information workers

Changes in contact 516 patterns shape the dynamics of the COVID-19 outbreak in China

Potential Presymptomatic Transmission of SARS-CoV-2